Device to remove cell waste from blood for severe pancreatitis
Part of Digestive system clinical trials.
This trial tests a device that filters blood to remove waste products that may worsen pancreatitis. It aims to see if the device is safe and helps people with severe pancreatitis recover.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have acute pancreatitis, which means sudden inflammation of the pancreas, confirmed by a doctor.
- You have at least one organ failure (like breathing, blood pressure, or kidneys) that has lasted for more than 12 hours but less than 72 hours.
- You have not had major surgery on your pancreas in the past and do not have long-term pancreas problems.
- You are not pregnant, not on dialysis, and not currently in another clinical trial.
- You do not have severe bleeding, liver cirrhosis, or a known allergy to the device materials.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new freezing tool to remove dead tissue from the pancreas after acute pancreatitis. It might help you if you have a large, painful collection of dead tissue that needs to be cleaned out through a tube down your throat.
This study looks at specific blood “immune” signatures and how they relate to outcomes in people with acute pancreatitis. If you enroll early, it may help doctors better predict how the illness will go and identify who might need more care.
This trial compares two ways of clearing “walled-off” dead tissue in the pancreas using an endoscope—one is standard tools, the other is the EndoRotor® system. It aims to see which approach is safer and works better after you’ve already had drainage.
This trial tests an investigational medicine called SGC001 given as an injection to people with severe acute pancreatitis, a serious inflammation of the pancreas. The study aims to see if the drug is safe and helpful, and to gather early information on how it works.
This trial collects blood samples from people with infected pancreatic necrosis to find patterns that help diagnose the condition. The goal is to reduce the need for invasive tests and start treatment faster.
This trial tests whether a fecal microbiota transplant (FMT) can help prevent infections in people with moderately severe or severe acute pancreatitis. You may qualify if you are between 18 and 75, have had pancreatitis for 15 to 21 days, and already have a feeding tube in place.
Hear when a new Acute Pancreatitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.